| Target Species |
Dogs |
| Active Substances |
Leptospira interrogans serogroup Australis, Leptospira interrogans serogroup Canicola, Leptospira interrogans serogroup Grippotyphosa, Leptospira interrogans serogroup Icterohaemorrhagiae |
| Pharmaceutical Form |
Suspension for injection |
| Therapeutic Group |
Inactivated Bacterial Vaccine |
| Authorisation Route |
National |
| Legal Category |
POM-V |
| Controlled Drug Status |
Not a controlled drug |
| Marketing Authorisation Holder |
Boehringer Ingelheim Vetmedica GmbH |
| Distributors |
<span>Boehringer Ingelheim Vetmedica GmbH</span> |
| Territory |
Great Britain |
| SPC |
Eurican L4 Suspension for Injection SPC |
| UKPAR |
Eurican L4 Suspension for Injection UKPAR |
